Should You Buy Aphria (TSX:APHA) on the Dip?

Aphria Inc (TSX:APHA)(NYSE:APHA) has been falling since the highs it reached earlier in the month, and that may have created a great buying opportunity for investors today.

edit Person using calculator next to charts and graphs

Image source: Getty Images.

August was looking like it would be a very good month for Aphria (TSX:APHA)(NYSE:APHA) after the stock soared on a good earnings report. However, since then, the stock has faltered, and it has dropped in value along with other cannabis stocks.

On Monday, Aphria’s stock closed at $8.45 — a big fall from the high of more than $10 a share that it reached earlier in the month. For investors, it could be a good opportunity to get back in at a lower price. After all, nothing has changed from the start of the month to the end that has drastically made Aphria a worse investment.

Valuation still looks decent

Aphria is not as overpriced as some of its peers, and with the decline in value, it might be a less risky investment overall. At around 1.2 times book value and nine times its sales, those are some modest multiples in an industry that’s been dominated by astronomical valuations.

One of the reasons for that, however, is that the stock has just not seen the same excitement that a stock like Canopy Growth has. Aphria has, unfortunately, provided investors with less-than-impressive returns, and that’s why it hasn’t had to come down a lot in price to be an appealing value today.

Why it’s a great opportunity to buy the stock

The company’s latest earnings report helped to re-establish Aphria as one of the top stocks in the industry. With strong sales growth and a profitable bottom line, it has attracted the attention of investors in a way that we haven’t seen in a while.

When also taking into consideration that recent struggles that Canopy Growth has faced, there could be a real opportunity for Aphria to move up the totem pole. While it would take a lot for investors to ditch Canopy Growth and buy Aphria instead, there’s going to be more of an appetite for that than there may have been in the past. Especially with poor earnings and a whole lot of uncertainty weighing Canopy Growth down as of late.

Pot stocks normally move together, as the general outlook for the industry can play a big role in whether stocks like Aphria or Canopy Growth rise in value. Even if the companies are doing well, if investors are concerned about the outlook for marijuana, it may not matter. Currently, we’re in a down cycle, but once things pick up again, perhaps as edibles get closer to launching, we could see another wave, which could send Aphria stock back up over $10.

Bottom line

Even though Aphria stock rallied earlier in the month, its share price has still taken a beating this year, as it’s down around 36% year to date. However, with the strong earnings and the stock generally seeing strong support at around $8 a share, it could prove to be a safe bet at its current price. While there’s always a risk that it could go lower, it seems unlikely to do so given the positivity around the stock today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »